Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Chemotherapy. Tianjin Medical University Cancer Institute and Hospital, Tianjin, China



Survival: 37.0 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs:
Country: China
   
City/State/Province: Tianjin
   
Hospital: Tianjin Medical University Cancer Institute and Hospital
   
Journal: Link
   
Date: 3/2015

Description:
Patients:
This study involved 49 refractory or relapsed T-Cell lymphoma patients. The median patient age was 50 years and 61.2% were male.

Treatment:
Patients received chemotherapy with gemcitabine, navelbine, and doxorubicin.

Toxicities:
The most severe toxicities were of grade 4 and included grade 3-4 neutropenia and leukopenia. Grade 1-2 nausea and fatigue were also reported.

Results:
The median overall survival was 37 months.

Correspondence: Dr. HuaqingWang; email: huaqingw@163.com

E-mail to a Friend Email Physician More Information